Parnell Pharmaceuticals Holdings Ltd (PARNF)
0.00
USD |
OTCM |
May 02, 16:00
Parnell Pharmaceuticals Holdings Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.99% |
March 31, 2024 | 99.99% |
February 29, 2024 | 99.99% |
January 31, 2024 | 99.99% |
December 31, 2023 | 99.99% |
November 30, 2023 | 99.99% |
October 31, 2023 | 99.99% |
September 30, 2023 | 99.99% |
August 31, 2023 | 99.99% |
July 31, 2023 | 99.99% |
June 30, 2023 | 99.99% |
May 31, 2023 | 99.99% |
April 30, 2023 | 99.99% |
March 31, 2023 | 99.99% |
February 28, 2023 | 99.99% |
January 31, 2023 | 99.99% |
December 31, 2022 | 99.99% |
November 30, 2022 | 99.99% |
October 31, 2022 | 99.99% |
September 30, 2022 | 99.99% |
August 31, 2022 | 99.99% |
July 31, 2022 | 99.99% |
June 30, 2022 | 99.99% |
May 31, 2022 | 99.99% |
April 30, 2022 | 99.99% |
Date | Value |
---|---|
March 31, 2022 | 99.99% |
February 28, 2022 | 99.99% |
January 31, 2022 | 99.99% |
December 31, 2021 | 99.99% |
November 30, 2021 | 99.99% |
October 31, 2021 | 99.27% |
September 30, 2021 | 99.27% |
August 31, 2021 | 99.27% |
July 31, 2021 | 99.27% |
June 30, 2021 | 99.27% |
May 31, 2021 | 99.27% |
April 30, 2021 | 99.27% |
March 31, 2021 | 99.27% |
February 28, 2021 | 99.27% |
January 31, 2021 | 99.27% |
December 31, 2020 | 99.27% |
November 30, 2020 | 99.27% |
October 31, 2020 | 99.27% |
September 30, 2020 | 99.27% |
August 31, 2020 | 99.27% |
July 31, 2020 | 99.27% |
June 30, 2020 | 99.27% |
May 31, 2020 | 99.27% |
April 30, 2020 | 99.27% |
March 31, 2020 | 99.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.96%
Minimum
May 2019
99.99%
Maximum
Nov 2021
99.58%
Average
99.63%
Median
Max Drawdown (5Y) Benchmarks
Alterity Therapeutics Ltd | 95.96% |
Kazia Therapeutics Ltd | 98.63% |
Immutep Ltd | 93.55% |
Opthea Ltd | 92.46% |
Mesoblast Ltd | 95.66% |